Immunitybio to host investor day

Culver city, calif.--(business wire)--immunitybio, inc. (nasdaq: ibrx), a leading immunotherapy company, invites current and prospective investors to its investor day program to be held on tuesday, april 15, 2025, at 10:00 am pdt. the program will include an in-depth update on the company's business operations and recent r&d advancements. key timelines for catalysts of product candidates will be presented, along with a discussion of ongoing clinical trials. “immunitybio commenced 2025 with.
IBRX Ratings Summary
IBRX Quant Ranking